corporate

Ipsen provides update on legacy of Henri Beaufour

PARIS, FRANCE, 5 December 2025, Ipsen (Euronext: IPN; ADR: IPSEY) has been informed that the shares of Beech Tree will be…

12 hours ago

IndiaFirst Life Enters Strategic Corporate Agency Tie-Up with Dombivli Nagari Sahakari Bank

MUMBAI, India, Dec. 4, 2025 /PRNewswire/ -- IndiaFirst Life Insurance Company Ltd. (IndiaFirst Life) has become the Bancassurance partner of…

1 day ago

MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress

Topline results from Phase 2 ZEPHYR trial of ML-007C-MA for schizophrenia expected in the second half of 2026Topline results from…

1 day ago

TraceLink Announces 2025 Corporate Grant Recipients Driving Global Community Impact

Through this annual program, TraceLink champions global health equity, community resilience, and shared purposeSummaryTraceLink announced the eight global nonprofit recipients…

3 days ago

Interlace Showcases “Capital Agility” as the New Corporate Financial Edge at Hong Kong FinTech Week 2025

HONG KONG, Nov. 5, 2025 /PRNewswire/ -- November 3–7, 2025 – Hong Kong: Hong Kong FinTech Week 2025, one of…

1 month ago

FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

October 31, 2025 16:30 ET  | Source: FibroBiologics, Inc. Advancing preparations to begin manufacturing of fibroblast-based spheroids product candidate, CYWC628,…

1 month ago

ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium

Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data…

1 month ago

Alps Blockchain Announces Corporate Rebranding to Alps

Reflecting its evolution into a global builder of next-generation data center infrastructure powering Bitcoin and, in the future, AI computation TRENTO,…

1 month ago

ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025

 Study data also showed prolonged progression-free survival with 177Lu-edotreotide compared to everolimus across patient subgroups Berlin, Germany, October 18, 2025…

2 months ago

Renewal Fuels, Inc. Announces Comprehensive Corporate Reset and Strategic Growth Initiative

LAS VEGAS, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Renewal Fuels, Inc. (OTC: RNWF) ("Renewal Fuels" or the "Company") today announced…

2 months ago